Drug Profile
Collagenase injection - Matrizyme
Alternative Names: MZ-004Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Matrizyme
- Class Cicatrizants; Collagenases
- Mechanism of Action Collagen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Arterial occlusive disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Arterial-occlusive-disorders in Canada (Intracoronary, Injection)
- 01 Nov 2009 Phase-I clinical trials in Arterial occlusive disorders in Canada (Intracoronary)